Tussin DM

Product NDC
67510-0527
11-digit product format
675100527
Labeler code
67510
Product ID
67510-0527_c9e1677e-3bca-499d-beb1-309aeb11bd0b
Type
HUMAN OTC DRUG
Nonproprietary name
Dextromethorphan HBr, Guaifenesin
Dosage form
LIQUID
Route
ORAL
Labeler
Kareway Product, Inc.
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2011-08-26
Marketing end
0000-00-00
Substance
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Active strength
10 mg/5mL; mg/5mL
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct67510-0527IInactivated by FDA2026-10-21
excluded packagepackage67510-052767510-0527-4IInactivated by FDA2026-10-21

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage67510-0527-4d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage67510-0527-4f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage67510-0527-42ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage67510-0527-4a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage67510-0527-4cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage67510-0527-4cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage67510-0527-4302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage67510-0527-4ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage67510-0527-40efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage67510-0527-4ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage67510-0527-4367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage67510-0527-4557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproduct8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage67510-0527-48af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproduct834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage67510-0527-4834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproduct1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage67510-0527-41332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage67510-0527-4fb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproduct86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage67510-0527-486f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage67510-0527-4bd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproduct8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage67510-0527-48dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproducte2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage67510-0527-4e2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproduct9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage67510-0527-49bebd1f3094a…5416666fcb17…
2019-12-08 06:16 UTC · source 2019-12-05excluded productproduct110d247fa046…a55b01930146…
2019-12-08 06:16 UTC · source 2019-12-05excluded packagepackage67510-0527-4110d247fa046…a55b01930146…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4fe95224-f543-4dbb-9445-8cca122b48c8Product name120150609
e8718272-64cb-4436-969b-176c3067c8f4Product name120150609
106ff02a-57e1-4c4c-a307-fd582ff4e311Product name120150212

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
67510-0527-42019-10-29C16284748780-1960f7f55-d5f8-8e05-e053-dbdaa90a074aDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67510-0527-4Tussin DM1 in 1 BOXLIQUID11
67510-0527-4Tussin DM120 mL in 1 BOTTLELIQUID1201

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DEXTROMETHORPHAN HYDROBROMIDEACTIVE INGREDIENT9D2RTI9KYHTUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
GUAIFENESINACTIVE INGREDIENT495W7451VQTUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
DEXTROMETHORPHANACTIVE MOIETY7355X3ROTSTUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
GUAIFENESINACTIVE MOIETY495W7451VQTUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
CHERRYINACTIVE INGREDIENTBUC5I9595WTUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPTUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOATUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXTUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
MENTHOLINACTIVE INGREDIENTL7T10EIP3ATUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
POLYSORBATE 20INACTIVE INGREDIENT7T1F30V5YHTUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3TUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUTUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
SORBITOLINACTIVE INGREDIENT506T60A25RTUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
SUCRALOSEINACTIVE INGREDIENT96K6UQ3ZD4TUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
SUCROSEINACTIVE INGREDIENTC151H8M554TUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
WATERINACTIVE INGREDIENT059QF0KO0RTUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEETUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67510-0527TUSSIN DM (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [KAREWAY PRODUCT, INC.]1Legacy NDC, 2 package rows20110831_e2314ad3-51d2-43aa-b7b0-23c0c7ae6e4d.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
996520dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral SolutionPSNe2314ad3-51d2-43aa-b7b0-23c0c7ae6e4d1
996520dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral SolutionSCDe2314ad3-51d2-43aa-b7b0-23c0c7ae6e4d1
996520dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 5 ML Oral SolutionSYe2314ad3-51d2-43aa-b7b0-23c0c7ae6e4d1
996520dextromethorphan hydrobromide 15 MG / guaifenesin 150 MG per 7.5 ML Oral SolutionSYe2314ad3-51d2-43aa-b7b0-23c0c7ae6e4d1
996520dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 10 ML Oral SolutionSYe2314ad3-51d2-43aa-b7b0-23c0c7ae6e4d1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
67510-0527-4675100527041 in 1 BOXHistorical